GL1X · GenesisL1 explorer

MolNFT v1 · #478277 · protein

AlphaFold monomer V2.0 prediction for transient receptor potential cation channel subfamily V member 3 (Q8NET8)

Q8NET8: “AlphaFold monomer V2.0 prediction for transient receptor potential cation channel subfamily V member 3…”. 11 pockets (best druggability 0.67). MolNFT v1 #478277 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
Q8NET8
Type
protein
Length
790 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x9073C46348542FfE4327c3F363F9B51B22058e75
Molecule
Transient receptor potential cation channel subfamily V member 3
UniProt
Q8NET8
Pockets
11 · best druggability 0.67

Structure

1 distinct chain · 53% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransient receptor potential cation channel subfamily V member 3protein79053% helix, 4% strandQ8NET8

Pockets

11 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12120.670.8425empty
24550.660.7845empty
34950.650.7744empty
45510.630.7544empty
53510.600.7740empty

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 8V6K · Apo-state cryo-EM structure of human TRPV3 in cNW30 nanodiscs · an experimental structure of the same protein · chain A against B, TM-score 0.79
  • 8V6M · Inactivated-state cryo-EM structure of human TRPV3 in presence of tetrahydrocannabivarin… · an experimental structure of the same protein · chain A against A, TM-score 0.78
  • 8V6L · Open-state cryo-EM structure of human TRPV3 in presence of tetrahydrocannabivarin (THCV)… · an experimental structure of the same protein · chain A against A, TM-score 0.77
  • 8GKA · Human TRPV3 tetramer structure, closed conformation · an experimental structure of the same protein · chain A against B, TM-score 0.77

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.